Roche Pharma India has announced the launch of its Clinical Trial Excellence project in India with an objective to strengthen the capabilities of public health institutions to do clinical trials and drug research in the country. This will also enable the government hospitals to become the Centres of Excellence for Clinical Research in the country and move up the value chain.

Kalyan Singh Super Specialty Cancer Institute (KSSSCI) in Lucknow, Uttar Pradesh became the first institute to partner with Roche in this initiative.  KSSSCI is a 750-bedded state-of-the-art cancer center by the Uttar Pradesh government and is involved in cancer research and education.

In the first phase of this programme, Roche aims to partner with 10 government hospitals to drive excellence in clinical research by boosting their existing capabilities for conducting clinical trials as per global standards. 

Solutions to enable this include training of the research team, process development or enhancement, and digitisation of dossier submission and review by Ethics Committee, paving the way for more high quality clinical research focussing on innovative treatments and patient safety. 

V Simpson Emmanuel, MD & CEO of Roche Pharma India, said, "This collaboration positions us as knowledge partners, enabling the integration of cutting-edge clinical and digital skills. Our collective initiative is geared towards propelling the healthcare sector forward while also enhancing healthcare throughout India. This initiative is in line with the government's recently launched Research and Development (R&D) policy, aiming to bolster healthcare infrastructure while enhancing the skills and capabilities of healthcare professionals. With enhanced skills and capabilities, India will be better positioned to conduct clinical trials for disease prevalent in its population and improve access to medicines.”